✦ LIBER ✦

Parkinson disease: The controversy of levodopa toxicity in Parkinson disease

✍ Scribed by Zesiewicz, Theresa A.

Book ID: 118016434
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 101 KB
Volume: 8
Category: Article
ISSN: 1759-4758
DOI: 10.1038/nrneurol.2011.199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in the September, 2004 issue of __Movement__ Disorders (2004) 19 (9) 997–1005.

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the “gold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ Manfred Gerlach; Heinz Reichmann; Peter Riederer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.

Current controversies: Levodopa in the t

Current controversies: Levodopa in the treatment of Parkinson's disease

✍ Jagdish C. Sharma; M. Vassallo; I.N. Ross 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Reichmann, and Riederer and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.

Levodopa unresponsive symptoms in Parkin

Levodopa unresponsive symptoms in Parkinson disease

✍ Kapil Sethi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Levodopa has been the mainstay of symptomatic therapy for Parkinson Disease (PD) for 40 years providing benefit to virtually all patients. Levodopa therapy results in improved activities of daily living, enhanced quality of life, and improved mortality. However, the long-term use of levodopa is asso

Reply: Levodopa in the treatment of Park

Reply: Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract The original articles to which this Letter refers have published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Rei